Abstract
The evolution of percutaneous dilatational tracheostomy (PDT) reflects the growing procedural autonomy of intensivists and the shift toward resource-conscious, patient-centered critical care. Bedside PDT performed or led by trained intensivists or dedicated tracheostomy teams has been shown to be safe, cost-effective, and carries an important ethical advantage by avoiding transport-related risks and reducing preventable harm compared with surgical tracheostomy in the operating room. It avoids transport-related risks, enhances care continuity, and optimizes ICU workflow—benefits that proved vital during the COVID-19 pandemic. Broader adoption of intensivist-led bedside PDT should be viewed not merely as a clinical option, but as a professional and institutional imperative.
| Original language | English (US) |
|---|---|
| Article number | 100580 |
| Journal | Perioperative Care and Operating Room Management |
| Volume | 41 |
| DOIs | |
| State | Published - Dec 2025 |
All Science Journal Classification (ASJC) codes
- Surgery
- Critical Care and Intensive Care Medicine
- Medical–Surgical
- Anesthesiology and Pain Medicine
Fingerprint
Dive into the research topics of 'The future of percutaneous tracheostomy: Is it time to embrace intensivist-led bedside practice?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver